ArticlePloS one2026
Prenatal exposure to polycyclic aromatic hydrocarbons and birth outcomes in a pregnancy cohort in Nairobi, Kenya.
Article in PloS one, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
- Update of
Authors and funding
13 authors.
Funding
Abstract
Prenatal exposure to polycyclic aromatic hydrocarbons (PAHs) has been linked to lower birth weight (BW) and shorter gestational age (GA) at delivery. Most research has focused on populations in high-income countries, leaving low- and middle-income countries (LMICs) understudied. We examined associations between pregnancy urinary PAH metabolites and birth outcomes in a prospective cohort in Nairobi, Kenya. The study population was drawn from women and their newborn babies enrolled in a pregnancy cohort. Third-trimester urinary mono-hydroxylated PAH metabolites (OH-PAH) were measured and infant BW and GA were ascertained using medical record abstraction and self-report; BW-for-GA z-scores were computed. Linear and modified Poisson regression models were used to estimate the effects of five OH-PAHs on birth outcomes; Weighted Quantile Sum regression was used to explore OH-PAH mixture effects. Among 353 mother-infant pairs, the median infant BW was 3.2 kg and 7.6% were born preterm. All OH-PAH metabolites were present in urine of >99% of mothers. Individual OH-PAH concentrations were not associated with BW or BW-for-GA z-scores. One metabolite, 2-hydroxyphenanthrene, was associated with shortened gestation (RR = -1.6 day per doubling in concentration, 95% confidence interval: -3.1, -0.1). This association was attenuated after adjusting for self-reported exposure to household fuel and outdoor combustion and was strengthened among female infants, but not male infants, in sex-stratified analyses. Other metabolites and the OH-PAH mixture were not associated with birth outcomes. Our findings suggest that exposure to 2-hydroxyphenanthrene may have a modest adverse effect on pregnancy duration, with potential sex-specific differences in association. No associations were observed for markers of fetal growth. These results highlight need for further studies on sex-specific vulnerabilities and the role of environmental co-exposures in impacting birth outcomes in LMICs.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.